APO Research
Talk to an analyst

APO RESEARCH · REPORT

Scopolamine

Scopolamine is a medication used in the treatment of motion sickness and postoperative nausea and vomiting. Scopolamine is used to prevent nausea and vomiting caused by motion sickness or from anesthesia given during surgery.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Scopolamine is a medication used in the treatment of motion sickness and postoperative nausea and vomiting. Scopolamine is used to prevent nausea and vomiting caused by motion sickness or from anesthesia given during surgery.

Selected research

Industry Growth & Trends

Global Scopolamine Industry Growth and Trends Forecast to 2032

1 January 202694 pages

Choose your research edition.

Industry ResearchScopolamine Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Scopolamine Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Scopolamine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Scopolamine Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Scopolamine Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

Scopolamine is a medication used in the treatment of motion sickness and postoperative nausea and vomiting. Scopolamine is used to prevent nausea and vomiting caused by motion sickness or from anesthesia given during surgery.

The major players in global Scopolamine market include Alkaloids of Australia, Boehringer Ingelheim, Fine Chemicals Corporation, etc. The top 3 players occupy about 55% shares of the global market. Australia and Europe are main markets, they occupy about 60% of the global market. Scopolamine Hydrobromide is the main type, with a share about 45%. Patches is the main application, which holds a share about 60%.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Scopolamine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Scopolamine market size, estimates, and forecasts are presented in terms of sales volume (Kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Scopolamine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Scopolamine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Scopolamine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Scopolamine Market by Company

Alkaloids of Australia

Boehringer Ingelheim

Fine Chemicals Corporation

Phytex Australia

Alchem International

Guangzhou Hanfang

Alkaloids Corporation

Luyin

Scopolamine Segment by Type

Scopolamine Butylbromide

Scopolamine Hydrobromide

Others

Scopolamine Segment by Application

Tablets

Injection

Patches

Scopolamine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Scopolamine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Scopolamine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Scopolamine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Scopolamine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Scopolamine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Scopolamine Butylbromide Table 2. Major Company of Scopolamine Hydrobromide Table 3. Major Company of Others Table 4. Global Scopolamine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Scopolamine Sales by Type (2021-2026) & (Kg) Table 6. Global Scopolamine Sales Market Share in Volume by Type (2021-2026) Table 7. Global Scopolamine Sales by Type (2021-2026) & (US$ Million) Table 8. Global Scopolamine Sales Market Share in Value by Type (2021-2026) Table 9. Global Scopolamine Price by Type (2021-2026) & (US$/Kg) Table 10. Global Scopolamine Sales by Type (2027-2032) & (Kg) Table 11. Global Scopolamine Sales Market Share in Volume by Type (2027-2032) Table 12. Global Scopolamine Sales by Type (2027-2032) & (US$ Million) Table 13. Global Scopolamine Sales Market Share in Value by Type (2027-2032) Table 14. Global Scopolamine Price by Type (2027-2032) & (US$/Kg) Table 15. North America Scopolamine Sales by Type (2021-2026) & (Kg) Table 16. North America Scopolamine Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Scopolamine Sales by Type (2021-2026) & (Kg) Table 18. Europe Scopolamine Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Scopolamine Sales by Type (2021-2026) & (Kg) Table 20. Asia-Pacific Scopolamine Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Scopolamine Sales by Type (2021-2026) & (Kg) Table 22. Latin America Scopolamine Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Scopolamine Sales by Type (2021-2026) & (Kg) Table 24. Middle East and Africa Scopolamine Sales by Type (2021-2026) & (US$ Million) Table 25. Scopolamine Industry Trends Table 26. Scopolamine Industry Drivers Table 27. Scopolamine Industry Opportunities and Challenges Table 28. Scopolamine Industry Restraints Table 29. Global Scopolamine Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Scopolamine Revenue Market Share by Company (2021-2026) Table 31. Global Scopolamine Sales by Company (2021-2026) & (Kg) Table 32. Global Scopolamine Sales Share by Company (2021-2026) Table 33. Global Scopolamine Market Price by Company (2021-2026) & (US$/Kg) Table 34. Global Scopolamine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Scopolamine Major Company Production Sites and Headquarters Table 36. Global Scopolamine Company, Product Type & Application Table 37. Global Scopolamine Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Scopolamine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Scopolamine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Scopolamine Sales by Region (2021-2026) & (Kg) Table 42. Global Scopolamine Sales Market Share in Volume by Region (2021-2026) Table 43. Global Scopolamine Sales by Region (2021-2026) & (US$ Million) Table 44. Global Scopolamine Sales Market Share in Value by Region (2021-2026) Table 45. Global Scopolamine Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 46. Global Scopolamine Sales by Region (2027-2032) & (Kg) Table 47. Global Scopolamine Sales Market Share in Volume by Region (2027-2032) Table 48. Global Scopolamine Sales by Region (2027-2032) & (US$ Million) Table 49. Global Scopolamine Sales Market Share in Value by Region (2027-2032) Table 50. Global Scopolamine Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2027-2032) Table 51. Global Scopolamine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Scopolamine Sales by Application (2021-2026) & (Kg) Table 53. Global Scopolamine Sales Market Share in Volume by Application (2021-2026) Table 54. Global Scopolamine Sales by Application (2021-2026) & (US$ Million) Table 55. Global Scopolamine Sales Market Share in Value by Application (2021-2026) Table 56. Global Scopolamine Price by Application (2021-2026) & (US$/Kg) Table 57. Global Scopolamine Sales by Application (2027-2032) & (Kg) Table 58. Global Scopolamine Sales Market Share in Volume by Application (2027-2032) Table 59. Global Scopolamine Sales by Application (2027-2032) & (US$ Million) Table 60. Global Scopolamine Sales Market Share in Value by Application (2027-2032) Table 61. Global Scopolamine Price by Application (2027-2032) & (US$/Kg) Table 62. North America Scopolamine Sales by Application (2021-2026) & (Kg) Table 63. North America Scopolamine Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Scopolamine Sales by Application (2021-2026) & (Kg) Table 65. Europe Scopolamine Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Scopolamine Sales by Application (2021-2026) & (Kg) Table 67. Asia-Pacific Scopolamine Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Scopolamine Sales by Application (2021-2026) & (Kg) Table 69. Latin America Scopolamine Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Scopolamine Sales by Application (2021-2026) & (Kg) Table 71. Middle East and Africa Scopolamine Sales by Application (2021-2026) & (US$ Million) Table 72. Alkaloids of Australia Company Information Table 73. Alkaloids of Australia Business Overview Table 74. Alkaloids of Australia Scopolamine Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 75. Alkaloids of Australia Scopolamine Product Portfolio Table 76. Alkaloids of Australia Recent Development Table 77. Boehringer Ingelheim Company Information Table 78. Boehringer Ingelheim Business Overview Table 79. Boehringer Ingelheim Scopolamine Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 80. Boehringer Ingelheim Scopolamine Product Portfolio Table 81. Boehringer Ingelheim Recent Development Table 82. Fine Chemicals Corporation Company Information Table 83. Fine Chemicals Corporation Business Overview Table 84. Fine Chemicals Corporation Scopolamine Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 85. Fine Chemicals Corporation Scopolamine Product Portfolio Table 86. Fine Chemicals Corporation Recent Development Table 87. Phytex Australia Company Information Table 88. Phytex Australia Business Overview Table 89. Phytex Australia Scopolamine Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 90. Phytex Australia Scopolamine Product Portfolio Table 91. Phytex Australia Recent Development Table 92. Alchem International Company Information Table 93. Alchem International Business Overview Table 94. Alchem International Scopolamine Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 95. Alchem International Scopolamine Product Portfolio Table 96. Alchem International Recent Development Table 97. Guangzhou Hanfang Company Information Table 98. Guangzhou Hanfang Business Overview Table 99. Guangzhou Hanfang Scopolamine Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 100. Guangzhou Hanfang Scopolamine Product Portfolio Table 101. Guangzhou Hanfang Recent Development Table 102. Alkaloids Corporation Company Information Table 103. Alkaloids Corporation Business Overview Table 104. Alkaloids Corporation Scopolamine Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 105. Alkaloids Corporation Scopolamine Product Portfolio Table 106. Alkaloids Corporation Recent Development Table 107. Luyin Company Information Table 108. Luyin Business Overview Table 109. Luyin Scopolamine Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 110. Luyin Scopolamine Product Portfolio Table 111. Luyin Recent Development Table 112. North America Scopolamine Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 113. North America Scopolamine Sales by Country (2021-2026) & (Kg) Table 114. North America Scopolamine Sales Market Share by Country (2021-2026) Table 115. North America Scopolamine Sales Forecast by Country (2027-2032) & (Kg) Table 116. North America Scopolamine Sales Market Share Forecast by Country (2027-2032) Table 117. North America Scopolamine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. North America Scopolamine Market Size by Country (2021-2026) & (US$ Million) Table 119. North America Scopolamine Market Share by Country (2021-2026) Table 120. North America Scopolamine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. North America Scopolamine Market Share Forecast by Country (2027-2032) Table 122. Europe Scopolamine Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 123. Europe Scopolamine Sales by Country (2021-2026) & (Kg) Table 124. Europe Scopolamine Sales Market Share by Country (2021-2026) Table 125. Europe Scopolamine Sales Forecast by Country (2027-2032) & (Kg) Table 126. Europe Scopolamine Sales Market Share Forecast by Country (2027-2032) Table 127. Europe Scopolamine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Europe Scopolamine Market Size by Country (2021-2026) & (US$ Million) Table 129. Europe Scopolamine Market Share by Country (2021-2026) Table 130. Europe Scopolamine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Europe Scopolamine Market Share Forecast by Country (2027-2032) Table 132. Asia-Pacific Scopolamine Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 133. Asia-Pacific Scopolamine Sales by Country (2021-2026) & (Kg) Table 134. Asia-Pacific Scopolamine Sales Market Share by Country (2021-2026) Table 135. Asia-Pacific Scopolamine Sales Forecast by Country (2027-2032) & (Kg) Table 136. Asia-Pacific Scopolamine Sales Market Share Forecast by Country (2027-2032) Table 137. Asia-Pacific Scopolamine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Asia-Pacific Scopolamine Market Size by Country (2021-2026) & (US$ Million) Table 139. Asia-Pacific Scopolamine Market Share by Country (2021-2026) Table 140. Asia-Pacific Scopolamine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Asia-Pacific Scopolamine Market Share Forecast by Country (2027-2032) Table 142. Latin America Scopolamine Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 143. Latin America Scopolamine Sales by Country (2021-2026) & (Kg) Table 144. Latin America Scopolamine Sales Market Share by Country (2021-2026) Table 145. Latin America Scopolamine Sales Forecast by Country (2027-2032) & (Kg) Table 146. Latin America Scopolamine Sales Market Share Forecast by Country (2027-2032) Table 147. Latin America Scopolamine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Latin America Scopolamine Market Size by Country (2021-2026) & (US$ Million) Table 149. Latin America Scopolamine Market Share by Country (2021-2026) Table 150. Latin America Scopolamine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Latin America Scopolamine Market Share Forecast by Country (2027-2032) Table 152. Middle East and Africa Scopolamine Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 153. Middle East and Africa Scopolamine Sales by Country (2021-2026) & (Kg) Table 154. Middle East and Africa Scopolamine Sales Market Share by Country (2021-2026) Table 155. Middle East and Africa Scopolamine Sales Forecast by Country (2027-2032) & (Kg) Table 156. Middle East and Africa Scopolamine Sales Market Share Forecast by Country (2027-2032) Table 157. Middle East and Africa Scopolamine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Middle East and Africa Scopolamine Market Size by Country (2021-2026) & (US$ Million) Table 159. Middle East and Africa Scopolamine Market Share by Country (2021-2026) Table 160. Middle East and Africa Scopolamine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Middle East and Africa Scopolamine Market Share Forecast by Country (2027-2032) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Scopolamine Distributors List Table 165. Scopolamine Customers List Table 166. Research Programs/Design for This Report Table 167. Authors List of This Report Table 168. Secondary Sources Table 169. Primary Sources List of Figures Figure 1. Scopolamine Image Figure 2. Global Scopolamine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Scopolamine Market Size (2021-2032) & (US$ Million) Figure 4. Global Scopolamine Sales (2021-2032) & (Kg) Figure 5. Scopolamine Butylbromide Image Figure 6. Global Scopolamine Butylbromide Sales YoY Growth (2021-2032) & (Kg) Figure 7. Scopolamine Hydrobromide Image Figure 8. Global Scopolamine Hydrobromide Sales YoY Growth (2021-2032) & (Kg) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (Kg) Figure 11. Global Scopolamine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Scopolamine Market Share by Type 2025 VS 2032 Figure 13. North America Scopolamine Sales Market Share in Volume by Type in 2025 Figure 14. North America Scopolamine Sales Market Share in Value by Type in 2025 Figure 15. Europe Scopolamine Sales Market Share in Volume by Type in 2025 Figure 16. Europe Scopolamine Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Scopolamine Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Scopolamine Sales Market Share in Value by Type in 2025 Figure 19. Latin America Scopolamine Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Scopolamine Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Scopolamine Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Scopolamine Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Scopolamine Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Tablets Image Figure 26. Global Tablets Sales YoY Growth (2021-2032) & (Kg) Figure 27. Injection Image Figure 28. Global Injection Sales YoY Growth (2021-2032) & (Kg) Figure 29. Patches Image Figure 30. Global Patches Sales YoY Growth (2021-2032) & (Kg) Figure 31. Global Scopolamine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Scopolamine Market Share by Application 2025 VS 2032 Figure 33. North America Scopolamine Sales Market Share in Volume by Application in 2025 Figure 34. North America Scopolamine Sales Market Share in Value by Application in 2025 Figure 35. Europe Scopolamine Sales Market Share in Volume by Application in 2025 Figure 36. Europe Scopolamine Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Scopolamine Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Scopolamine Sales Market Share in Value by Application in 2025 Figure 39. Latin America Scopolamine Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Scopolamine Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Scopolamine Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Scopolamine Sales Market Share in Value by Application in 2025 Figure 43. North America Scopolamine Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 44. North America Scopolamine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Scopolamine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Scopolamine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Scopolamine Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 48. Europe Scopolamine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Scopolamine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Scopolamine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Scopolamine Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 52. Asia-Pacific Scopolamine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Scopolamine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Scopolamine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Scopolamine Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 56. Latin America Scopolamine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Scopolamine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Scopolamine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Scopolamine Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 60. Middle East and Africa Scopolamine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Scopolamine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Scopolamine Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Scopolamine Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Scopolamine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Scopolamine Butylbromide
  • Scopolamine Hydrobromide
  • Others
Applications
  • Tablets
  • Injection
  • Patches
Companies covered
  • Alkaloids of Australia
  • Boehringer Ingelheim
  • Fine Chemicals Corporation
  • Phytex Australia
  • Alchem International
  • Guangzhou Hanfang
  • Alkaloids Corporation
  • Luyin

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Scopolamine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Scopolamine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Scopolamine Market by Type
  6. 1.3.1 Scopolamine Butylbromide
  7. 1.3.2 Scopolamine Hydrobromide
  8. 1.3.3 Others
  9. 1.4 Global Scopolamine Market Size by Type
  10. 1.4.1 Global Scopolamine Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Scopolamine Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Scopolamine Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Scopolamine Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Scopolamine Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Scopolamine Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Scopolamine Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Scopolamine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Scopolamine Industry Trends
  2. 2.2 Scopolamine Industry Drivers
  3. 2.3 Scopolamine Industry Opportunities and Challenges
  4. 2.4 Scopolamine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Scopolamine Revenue (2021-2026)
  2. 3.2 Global Top Players by Scopolamine Sales (2021-2026)
  3. 3.3 Global Top Players by Scopolamine Price (2021-2026)
  4. 3.4 Global Scopolamine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Scopolamine Major Company Production Sites & Headquarters
  6. 3.6 Global Scopolamine Company, Product Type & Application
  7. 3.7 Global Scopolamine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Scopolamine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Scopolamine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Scopolamine Tier 1, Tier 2, and Tier 3
4 Scopolamine Regional Status and Outlook
  1. 4.1 Global Scopolamine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Scopolamine Historic Market Size by Region
  3. 4.2.1 Global Scopolamine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Scopolamine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Scopolamine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Scopolamine Forecasted Market Size by Region
  7. 4.3.1 Global Scopolamine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Scopolamine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Scopolamine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Scopolamine by Application
  1. 5.1 Scopolamine Market by Application
  2. 5.1.1 Tablets
  3. 5.1.2 Injection
  4. 5.1.3 Patches
  5. 5.2 Global Scopolamine Market Size by Application
  6. 5.2.1 Global Scopolamine Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Scopolamine Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Scopolamine Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Scopolamine Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Scopolamine Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Scopolamine Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Scopolamine Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Scopolamine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Alkaloids of Australia
  2. 6.1.1 Alkaloids of Australia Company Information
  3. 6.1.2 Alkaloids of Australia Business Overview
  4. 6.1.3 Alkaloids of Australia Scopolamine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Alkaloids of Australia Scopolamine Product Portfolio
  6. 6.1.5 Alkaloids of Australia Recent Developments
  7. 6.2 Boehringer Ingelheim
  8. 6.2.1 Boehringer Ingelheim Company Information
  9. 6.2.2 Boehringer Ingelheim Business Overview
  10. 6.2.3 Boehringer Ingelheim Scopolamine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Boehringer Ingelheim Scopolamine Product Portfolio
  12. 6.2.5 Boehringer Ingelheim Recent Developments
  13. 6.3 Fine Chemicals Corporation
  14. 6.3.1 Fine Chemicals Corporation Company Information
  15. 6.3.2 Fine Chemicals Corporation Business Overview
  16. 6.3.3 Fine Chemicals Corporation Scopolamine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Fine Chemicals Corporation Scopolamine Product Portfolio
  18. 6.3.5 Fine Chemicals Corporation Recent Developments
  19. 6.4 Phytex Australia
  20. 6.4.1 Phytex Australia Company Information
  21. 6.4.2 Phytex Australia Business Overview
  22. 6.4.3 Phytex Australia Scopolamine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Phytex Australia Scopolamine Product Portfolio
  24. 6.4.5 Phytex Australia Recent Developments
  25. 6.5 Alchem International
  26. 6.5.1 Alchem International Company Information
  27. 6.5.2 Alchem International Business Overview
  28. 6.5.3 Alchem International Scopolamine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Alchem International Scopolamine Product Portfolio
  30. 6.5.5 Alchem International Recent Developments
  31. 6.6 Guangzhou Hanfang
  32. 6.6.1 Guangzhou Hanfang Company Information
  33. 6.6.2 Guangzhou Hanfang Business Overview
  34. 6.6.3 Guangzhou Hanfang Scopolamine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Guangzhou Hanfang Scopolamine Product Portfolio
  36. 6.6.5 Guangzhou Hanfang Recent Developments
  37. 6.7 Alkaloids Corporation
  38. 6.7.1 Alkaloids Corporation Company Information
  39. 6.7.2 Alkaloids Corporation Business Overview
  40. 6.7.3 Alkaloids Corporation Scopolamine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Alkaloids Corporation Scopolamine Product Portfolio
  42. 6.7.5 Alkaloids Corporation Recent Developments
  43. 6.8 Luyin
  44. 6.8.1 Luyin Company Information
  45. 6.8.2 Luyin Business Overview
  46. 6.8.3 Luyin Scopolamine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Luyin Scopolamine Product Portfolio
  48. 6.8.5 Luyin Recent Developments
7 North America by Country
  1. 7.1 North America Scopolamine Sales by Country
  2. 7.1.1 North America Scopolamine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Scopolamine Sales by Country (2021-2026)
  4. 7.1.3 North America Scopolamine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Scopolamine Market Size by Country
  6. 7.2.1 North America Scopolamine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Scopolamine Market Size by Country (2021-2026)
  8. 7.2.3 North America Scopolamine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Scopolamine Sales by Country
  2. 8.1.1 Europe Scopolamine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Scopolamine Sales by Country (2021-2026)
  4. 8.1.3 Europe Scopolamine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Scopolamine Market Size by Country
  6. 8.2.1 Europe Scopolamine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Scopolamine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Scopolamine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Scopolamine Sales by Country
  2. 9.1.1 Asia-Pacific Scopolamine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Scopolamine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Scopolamine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Scopolamine Market Size by Country
  6. 9.2.1 Asia-Pacific Scopolamine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Scopolamine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Scopolamine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Scopolamine Sales by Country
  2. 10.1.1 South America Scopolamine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Scopolamine Sales by Country (2021-2026)
  4. 10.1.3 South America Scopolamine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Scopolamine Market Size by Country
  6. 10.2.1 South America Scopolamine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Scopolamine Market Size by Country (2021-2026)
  8. 10.2.3 South America Scopolamine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Scopolamine Sales by Country
  2. 11.1.1 Middle East and Africa Scopolamine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Scopolamine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Scopolamine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Scopolamine Market Size by Country
  6. 11.2.1 Middle East and Africa Scopolamine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Scopolamine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Scopolamine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Scopolamine Value Chain Analysis
  2. 12.1.1 Scopolamine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Scopolamine Production Mode & Process
  7. 12.2 Scopolamine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Scopolamine Distributors
  10. 12.2.3 Scopolamine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst